News
Zacks Investment Research on MSN2d
FDA Grants Accelerated Approval to Regeneron's Blood Cancer DrugRegeneron Pharmaceuticals, Inc. REGN obtained FDA approval for linvoseltamab-gcpt for the treatment of relapsed or refractory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback